Clinical Research Directory
Browse clinical research sites, groups, and studies.
Efficacy And Safety Study Of Naftopidil to Patients Treatment With LUTS
Sponsor: Apsen Farmaceutica S.A.
Summary
The purpose of this study is to evaluate the effectiveness and safety of Naftopidil and Tamsulosin in the treatment of lower urinary tract symptoms through a comparative study of patients with benign prostatic hyperplasia.
Official title: PHASE III, DOUBLE-BLIND, RANDOMIZED STUDY COMPARING THE EFFICACY AND SAFETY OF NAFTOPIDIL AND TAMSULOSIN TO TREATMENT THE SYMPTOMS OF LOWER URINARY TRACT IN PATIENTS WITH BENIGN PROSTATE HYPERPLASIA
Key Details
Gender
MALE
Age Range
50 Years - 90 Years
Study Type
INTERVENTIONAL
Enrollment
0
Start Date
2011-01-01
Completion Date
2012-01-01
Last Updated
2026-09-09
Healthy Volunteers
No
Conditions
Interventions
Naftopidil
0,25 mg (2weeks) and 0,50 mg (10 weeks)
Tamsulosin
0,4 mg/day
Locations (1)
Hospital das Clínicas da Faculdade de Medicina da USP
São Paulo, São Paulo, Brazil